IBDEI0YP ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34922,1,3,0)
 ;;=3^Eosinophilic Cellulitis
 ;;^UTILITY(U,$J,358.3,34922,1,4,0)
 ;;=4^L98.3
 ;;^UTILITY(U,$J,358.3,34922,2)
 ;;=^5009576
 ;;^UTILITY(U,$J,358.3,34923,0)
 ;;=L40.1^^125^1650^18
 ;;^UTILITY(U,$J,358.3,34923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34923,1,3,0)
 ;;=3^Pustular Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,34923,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,34923,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,34924,0)
 ;;=L40.4^^125^1650^12
 ;;^UTILITY(U,$J,358.3,34924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34924,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,34924,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,34924,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,34925,0)
 ;;=L24.9^^125^1650^13
 ;;^UTILITY(U,$J,358.3,34925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34925,1,3,0)
 ;;=3^Irritant Contact Dermatitis
 ;;^UTILITY(U,$J,358.3,34925,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,34925,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,34926,0)
 ;;=L30.0^^125^1650^14
 ;;^UTILITY(U,$J,358.3,34926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34926,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,34926,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,34926,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,34927,0)
 ;;=L40.8^^125^1650^15
 ;;^UTILITY(U,$J,358.3,34927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34927,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,34927,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,34927,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,34928,0)
 ;;=L30.8^^125^1650^9
 ;;^UTILITY(U,$J,358.3,34928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34928,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,34928,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,34928,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,34929,0)
 ;;=L40.0^^125^1650^16
 ;;^UTILITY(U,$J,358.3,34929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34929,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,34929,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,34929,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,34930,0)
 ;;=L40.9^^125^1650^17
 ;;^UTILITY(U,$J,358.3,34930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34930,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,34930,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,34930,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,34931,0)
 ;;=L40.3^^125^1650^19
 ;;^UTILITY(U,$J,358.3,34931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34931,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,34931,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,34931,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,34932,0)
 ;;=R21.^^125^1650^20
 ;;^UTILITY(U,$J,358.3,34932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34932,1,3,0)
 ;;=3^Rash/Oth Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,34932,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,34932,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,34933,0)
 ;;=L25.9^^125^1650^6
 ;;^UTILITY(U,$J,358.3,34933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34933,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,34933,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,34933,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,34934,0)
 ;;=M34.89^^125^1651^22
 ;;^UTILITY(U,$J,358.3,34934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34934,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,34934,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,34934,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,34935,0)
 ;;=M34.0^^125^1651^20
 ;;^UTILITY(U,$J,358.3,34935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34935,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,34935,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,34935,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,34936,0)
 ;;=F03.90^^125^1651^14
 ;;^UTILITY(U,$J,358.3,34936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34936,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,34936,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,34936,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,34937,0)
 ;;=F06.8^^125^1651^17
 ;;^UTILITY(U,$J,358.3,34937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34937,1,3,0)
 ;;=3^Mental Disorders d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,34937,1,4,0)
 ;;=4^F06.8
 ;;^UTILITY(U,$J,358.3,34937,2)
 ;;=^5003062
 ;;^UTILITY(U,$J,358.3,34938,0)
 ;;=F06.1^^125^1651^1
 ;;^UTILITY(U,$J,358.3,34938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34938,1,3,0)
 ;;=3^Catatonic Disorder d/t Physiological Condition
 ;;^UTILITY(U,$J,358.3,34938,1,4,0)
 ;;=4^F06.1
 ;;^UTILITY(U,$J,358.3,34938,2)
 ;;=^5003054
 ;;^UTILITY(U,$J,358.3,34939,0)
 ;;=G35.^^125^1651^18
 ;;^UTILITY(U,$J,358.3,34939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34939,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,34939,1,4,0)
 ;;=4^G35.
 ;;^UTILITY(U,$J,358.3,34939,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,34940,0)
 ;;=G60.9^^125^1651^15
 ;;^UTILITY(U,$J,358.3,34940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34940,1,3,0)
 ;;=3^Hereditary/Idiopathic Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,34940,1,4,0)
 ;;=4^G60.9
 ;;^UTILITY(U,$J,358.3,34940,2)
 ;;=^5004071
 ;;^UTILITY(U,$J,358.3,34941,0)
 ;;=G62.9^^125^1651^19
 ;;^UTILITY(U,$J,358.3,34941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34941,1,3,0)
 ;;=3^Polyneuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,34941,1,4,0)
 ;;=4^G62.9
 ;;^UTILITY(U,$J,358.3,34941,2)
 ;;=^5004079
 ;;^UTILITY(U,$J,358.3,34942,0)
 ;;=I63.9^^125^1651^13
 ;;^UTILITY(U,$J,358.3,34942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34942,1,3,0)
 ;;=3^Cerebral Infarction,Unspec
 ;;^UTILITY(U,$J,358.3,34942,1,4,0)
 ;;=4^I63.9
 ;;^UTILITY(U,$J,358.3,34942,2)
 ;;=^5007355
 ;;^UTILITY(U,$J,358.3,34943,0)
 ;;=I63.50^^125^1651^7
 ;;^UTILITY(U,$J,358.3,34943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34943,1,3,0)
 ;;=3^Cerebral Infarction d/t Occls/Stenosis of Unspec Cerebral Artery
 ;;^UTILITY(U,$J,358.3,34943,1,4,0)
 ;;=4^I63.50
 ;;^UTILITY(U,$J,358.3,34943,2)
 ;;=^5007343
 ;;^UTILITY(U,$J,358.3,34944,0)
 ;;=I63.549^^125^1651^8
 ;;^UTILITY(U,$J,358.3,34944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34944,1,3,0)
 ;;=3^Cerebral Infarction d/t Occls/Stenosis of Unspec Cerebellar Artery
 ;;^UTILITY(U,$J,358.3,34944,1,4,0)
 ;;=4^I63.549
 ;;^UTILITY(U,$J,358.3,34944,2)
 ;;=^5133571
 ;;^UTILITY(U,$J,358.3,34945,0)
 ;;=I63.8^^125^1651^2
 ;;^UTILITY(U,$J,358.3,34945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34945,1,3,0)
 ;;=3^Cerebral Infarction NEC
 ;;^UTILITY(U,$J,358.3,34945,1,4,0)
 ;;=4^I63.8
 ;;^UTILITY(U,$J,358.3,34945,2)
 ;;=^5007354
 ;;^UTILITY(U,$J,358.3,34946,0)
 ;;=I63.512^^125^1651^5
 ;;^UTILITY(U,$J,358.3,34946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34946,1,3,0)
 ;;=3^Cerebral Infarction d/t Left Middle Cerebral Artery Occls/Stenosis
 ;;^UTILITY(U,$J,358.3,34946,1,4,0)
 ;;=4^I63.512
 ;;^UTILITY(U,$J,358.3,34946,2)
 ;;=^5007345
 ;;^UTILITY(U,$J,358.3,34947,0)
 ;;=I63.522^^125^1651^3
 ;;^UTILITY(U,$J,358.3,34947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34947,1,3,0)
 ;;=3^Cerebral Infarction d/t Left Anterior Cerebral Artery Occls/Stenosis
 ;;^UTILITY(U,$J,358.3,34947,1,4,0)
 ;;=4^I63.522
 ;;^UTILITY(U,$J,358.3,34947,2)
 ;;=^5007347
 ;;^UTILITY(U,$J,358.3,34948,0)
 ;;=I63.532^^125^1651^6
 ;;^UTILITY(U,$J,358.3,34948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34948,1,3,0)
 ;;=3^Cerebral Infarction d/t Left Posterior Cerebral Artery Occls/Stenosis
 ;;^UTILITY(U,$J,358.3,34948,1,4,0)
 ;;=4^I63.532
 ;;^UTILITY(U,$J,358.3,34948,2)
 ;;=^5007349
 ;;^UTILITY(U,$J,358.3,34949,0)
 ;;=I63.542^^125^1651^4
 ;;^UTILITY(U,$J,358.3,34949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34949,1,3,0)
 ;;=3^Cerebral Infarction d/t Left Cerebellar Artery Occls/Stenosis
 ;;^UTILITY(U,$J,358.3,34949,1,4,0)
 ;;=4^I63.542
 ;;^UTILITY(U,$J,358.3,34949,2)
 ;;=^5007351
 ;;^UTILITY(U,$J,358.3,34950,0)
 ;;=I63.511^^125^1651^11
